Clinical Trial: Comparison Between ER Loss and Triple-Negative Breast Cancer Guided by 18F-FES PET/CT in Metastatic Breast Cancer

U.S., Jan. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07316439) titled 'Comparison Between ER Loss and Triple-Negative Breast Cancer Guided by 18F-FES PET/CT in Metastatic Breast Cancer' on Dec. 19, 2025.

Brief Summary: This study aimed to compare survival outcomes and clinical characteristics between ER loss and metastatic triple-negative breast cancer (mTNBC) patients, exploring the prognostic implications of dynamic ER changes.

Study Start Date: Dec. 31, 2024

Study Type: OBSERVATIONAL

Condition: Breast Cancer

Recruitment Status: ACTIVE_NOT_RECRUITING

Sponsor: Fudan University

Information provided by (Responsible Party): Biyun Wang, MD, Fudan University

Published by HT Digital Content Services ...